Gao, Xin

Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity

Haas, E., Bhattacharya, I., Brailoiu, E., Damjanović, M., Brailoiu, G. C., Gao, X., Mueller-Guerre, L., Marjon, N. A., Gut, A., Minotti, R., et al. (2009) · Circulation Research

Estrogen and related hormone effectsReceptor Mechanisms and Signaling

Cited by 373

Patients’ report on how endometriosis affects health, work, and daily life

Fourquet, J., Gao, X., Zavala, D., Orengo, J. C., Abac, S., Ruiz, A., Laboy, J., & Flores, I. (2010) · Fertility and Sterility

Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and Management

Cited by 252

Health-related quality of life burden of women with endometriosis: a literature review

Gao, X., Yeh, Y.-C., Outley, J., Simon, J., Botteman, M., & Spalding, J. (2006) · Current Medical Research and Opinion

Endometriosis Research and TreatmentHealth Systems, Economic Evaluations, Quality of Life

Cited by 206

Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes

Shao, N., Kuang, H. Y., Hao, M., Gao, X. Y., Lin, W. J., & Zou, W. (2014) · Diabetes/Metabolism Research and Reviews

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 185

First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).

Petrylak, D. P., Gao, X., Vogelzang, N. J., Garfield, M. H., Taylor, I., Dougan Moore, M., Peck, R. A., & Burris, H. A. (2020) · Journal of Clinical Oncology

Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors

Cited by 169

Results of an ongoing phase 1/2a dose escalation study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager, in patients with metastatic castration-resistant prostate cancer (mCRPC).

De Bono, J. S., Fong, L., Beer, T. M., Gao, X., Geynisman, D. M., Burris III, H. A., Strauss, J. F., Courtney, K. D., Quinn, D. I., VanderWeele, D. J., et al. (2021) · Journal of Clinical Oncology

Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors

Cited by 39

Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center

Zubiri, L., Rosovsky, R. P., Mooradian, M. J., Piper-Vallillo, A. J., Gainor, J. F., Sullivan, R. J., Marte, D., Boland, G. M., Gao, X., Hochberg, E. P., et al. (2021) · The Oncologist

COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies

Cited by 19

Datopotamab deruxtecan in locally advanced/metastatic urothelial cancer: Preliminary results from the phase 1 TROPION-PanTumor01 study.

Lisberg, A., Drakaki, A., Meric-Bernstam, F., Alhalabi, O., Kojima, T., Kato, M., Spira, A. I., Salkeni, M. A., Heist, R., Gao, X., et al. (2024) · Journal of Clinical Oncology

Bladder and Urothelial Cancer TreatmentsLung Cancer Treatments and Mutations

Cited by 15

Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study

McIntyre, R. S., Prieto, R., Schepman, P., Yeh, Y.-C., Boucher, M., Shelbaya, A., Chambers, R., Gao, X., & Pappadopulos, E. (2019) · Current Medical Research and Opinion

Treatment of Major DepressionMental Health Treatment and Access

Cited by 15